NRSNW
#7436
NeuroSense Therapeutics Ltd. - Warrant
0.073 6 USD
-8.57%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-8.57%
Monthly Change
-54.00%
6 month change
-82.47%
Year Change
-83.64%
Previous Close
0.080 5
Open
0.100 0
Low
0.073 6
High
0.100 0
Volume
3
Financials
- Market Capitalization 27.0225 M
- Employee 16
- Founded 2017
- CEO N/A
- Website www.neurosense-tx.com
- Headquarter Israel
- FIGI N/A
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.7
Price to sales ratio
607.63